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mouse model of schizophrenia. This study will show further insight into possible mechanisms of the Ketogenic diet for 
future novel therapeutics. Method: 36 Young-C57/BL mice were randomly assigned to either Ketogenic or Standard diet 
for 7 weeks. Pre-pulse inhibition of startle (PPI) testing was performed at 3 and 7 weeks after commencement of the diet. 
The 2 diet groups were randomly assigned to either MK-801 or saline intra-peritoneal injection 30 minutes prior to PPI 
tests. Food intake was recorded daily and body weight weekly. Results: Energy consumption between diet groups did 
not differ significantly. Ketogenic diet improved average PPI per cent, which was shown across different pre pulse 
intensities. Average PPI per cent improvement was seen at 3 and 7 weeks. Conclusions: Energy consumption not being 
significantly different indicates that animals on Ketogenic diet are not starving. Ketogenic diet reconstitutes sensory motor 
gating at different time-points. Ketogenic diet has a significant effect on the gold standard test for schizophrenia in an 
acute NMDA receptor antagonist mouse model. However, future research is needed to investigate the efficacy of 
Ketogenic diet in chronic animal models of schizophrenia.  
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Background: Vascular diseases remain a cause of high patient mortality globally. Current diagnoses are often through 
contrast-enhanced computed-tomography or magnetic-resonance-imaging (MRI) with approximately 80% sensitivity. 
Iron oxide nanoparticles are increasingly used in enhancing vascular disease diagnosis due to their ability to selectively 
deliver imaging agents to specific locations. This article describes studies investigating the use of iron oxide nanoparticles 
in the diagnosis of vascular diseases in humans. Method: A literature search was conducted to identify studies assessing 
the role of nanoparticles in the management of vascular diseases using PubMed from Jan 2011 to June 2016. The 
following search terms were applied “vascular diseases” AND “nanoparticles”. Human studies investigating the role of 
nanoparticles in vascular diseases were included. Studies excluded were ex vivo and in vitro human association studies, 
and non-English studies. Results: Nine out of 179 studies met the inclusion criteria.  Sample size ranged from 1 to 23 
median 14, inter-quartile range (IQR, 5.5 - 20.0). Five studies reported that ultra-small super paramagnetic iron oxide 
(USPIO) enhanced MRI assessment of vascularity, and macrophage content in atherosclerotic carotid plaques. Three 
studies demonstrated that ultra-small super paramagnetic iron oxide improved MRI diagnosis of myocardial infarction 
and allows the detection of the peri-infarct zone. One study did not support the latter findings. Conclusions: Iron oxide 
nanoparticles are effective at improving detection and diagnosis of vascular diseases, although the long term effects of 
these agents are not yet known. 
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Background: Renal Cell Carcinoma (RCC) is the most common urogenital tumor, accounting for 3% of all adult 
malignancies, and is characterized by an increase in expression of hypoxia inducible factors (HIFs). In RCC, mutations 
in the VHL gene allow the HIFα subunits to escape degradation and translocate to the nucleus where they activate 
transcription of their target genes. Over 60 HIF target genes have been identified, which are involved in processes such 
as angiogenesis, erythropoeisis, glycolysis, apoptosis, and cell proliferation. Although both HIF1α and HIF2α are 
upregulated in RCC, it has been suggested that HIF2α plays a more critical role. Method: In this study we examined the 
contribution of HIF2α in renal tumourigenesis by generating a transgenic mouse model containing a mutated human 
HIF2α gene. Selective mutation of the Proline531 and Asparagine847 residues produced a stabilized HIF2α that escaped 
proteasomal degradation while remaining transcriptionally active. Under the control of the ROSA26, and Pax8 promoters, 
a reverse tetracycline-controlled system (rtTA) allowed for temporal control of whole body, and tubular-specific 
overexpression of HIF2α. Results: Increased expression of HIF2α in the renal tubular epithelium resulted in enhanced 
cellular proliferation, erythrocytosis, lipid-accumulation, and the rapid development of renal cysts that had lost markers 
of tubular epithelial differentiation – all features that are noted in the early stages of RCC. Conclusions: Taken together, 
these results suggest that HIF2α is a key player in the development of RCC, and a potential target for treatment of this 
disorder. 
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